Jeffrey Albert

Title: Celebrating the Innovations of Jeffrey Albert in Wilmington, DE

Introduction

Jeffrey Albert, a prominent inventor based in Wilmington, Delaware, has made significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Albert's innovative work primarily focuses on compounds with therapeutic applications, showcasing his dedication to advancing medical science.

Latest Patents

Among his latest inventions is a series of patents related to alkylsulphonamide quinolines. These patents detail compounds of Formula I where the specific variables, such as R, A, and others, are defined in the comprehensive specification. The inventions include pharmaceutically-acceptable salts, methods of making these compounds, as well as pharmaceutical compositions containing and methods for using the same. Additionally, Albert has developed alkyl sulfoxide quinolines as NK-3 receptor ligands, which also encompass compounds of Formula I with similar specifications as mentioned earlier.

Career Highlights

Jeffrey Albert is currently associated with AstraZeneca AB, a global leader in the pharmaceutical industry. His role within the company has been instrumental in fostering innovation and developing new therapeutic solutions. Albert’s work consistently reflects a commitment to scientific advancement and improving patient outcomes.

Collaborations

Throughout his career, Albert has collaborated with notable colleagues, including Thomas Richard Simpson and James Kang. These collaborations have amplified his ability to innovate, combining expertise to push the boundaries of current pharmaceutical research and development.

Conclusion

Jeffrey Albert’s impressive portfolio of patents highlights his significant contributions to the pharmaceutical industry. His innovative spirit and collaborative efforts with esteemed colleagues at AstraZeneca AB continue to drive forward the realm of medical advancements, making a lasting impact on healthcare solutions.